|
|
|
|
|
|
|
|
|
03.06.25 - 22:33
|
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 (GlobeNewswire EN)
|
|
|
ROCKVILLE, MD, June 03, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that members of the Company's management team will present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 on Tuesday, June 10, 2025, at 8:00am ET in Miami, FL....
|
|
|
20.05.25 - 22:51
|
4 Analysts Assess Macrogenics: What You Need To Know (Benzinga)
|
|
|
Latest Ratings for MGNX
DateFirmActionFromTo Feb 2022CitigroupUpgradesNeutralBuy Feb 2022SVB LeerinkMaintainsOutperform Feb 2022BMO CapitalInitiates Coverage OnOutperform
View More Analyst Ratings for MGNX
View the Latest Analyst Ratings
read more...
|
|
|
|
|
|
|
|
|
06.05.25 - 22:33
|
MacroGenics Announces Date of First Quarter 2025 Financial Results (GlobeNewswire EN)
|
|
|
ROCKVILLE, MD, May 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the first quarter of 2025 after the market closes on Tuesday, May 13, 2025. ...
|
|
|
01.05.25 - 22:33
|
MacroGenics to Participate in Upcoming Investor Conference (GlobeNewswire EN)
|
|
|
ROCKVILLE, MD, May 01, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that members of the Company's management team will participate in the following investor conference this month:...
|
|
|
|
|
|
|
|
|
|
|
20.03.25 - 21:06
|
MacroGenics Provides Update on Corporate Progress and 2024 Financial Results (GlobeNewswire EN)
|
|
|
ROCKVILLE, Md., March 20, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today provided an update on its recent corporate progress and reported financial results for the year ended December 31, 2024....
|
|
|
|
|
06.03.25 - 13:33
|
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call (GlobeNewswire EN)
|
|
|
ROCKVILLE, MD, March 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the fourth quarter and full year of 2024 after the market closes on Thursday, March 20, 2025. MacroGenics will host a conference call to discuss the financial results and recent corporate progress on Thursday, March 20, 2025, at 4:30 pm ET...
|
|
|
27.02.25 - 13:33
|
MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire EN)
|
|
|
ROCKVILLE, MD, Feb. 27, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conferences in March:...
|
|
|
|
|
02.12.24 - 22:33
|
MacroGenics to Participate in Upcoming Investor Conference (GlobeNewswire EN)
|
|
|
ROCKVILLE, MD, Dec. 02, 2024 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conference this month:...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
